The first time most people self-inject a peptide, they pick a spot on their belly, do the deed, and then return to that exact same spot week after week because it worked once and it did not hurt. That habit is precisely how you end up with a rubbery lump under the skin that quietly sabotages how well the drug absorbs. The fix is almost boringly simple, and it is the one step new injectors skip most.

Quick answer: Subcutaneous peptides like semaglutide and tirzepatide are injected into fatty tissue at three approved sites: the abdomen (at least two inches from the navel), the front or outer thigh, and the back of the upper arm. Rotate sites with each dose and stay at least one centimeter from any previous spot to prevent lumps that slow absorption.

Where can you actually inject a subcutaneous peptide?

Three places, and only three, for the common injectable peptides used in metabolic care. The FDA prescribing information for both Wegovy (semaglutide) and Ozempic (semaglutide) lists the abdomen, the thigh, and the upper arm as the approved subcutaneous sites, and tirzepatide products follow the same map. These are areas with a reliable layer of fat just under the skin, which is exactly where the medication is meant to land.

The abdomen is the workhorse. It is the easiest to reach, the easiest to see, and it has a forgiving fat pad in most adults. Keep at least two inches of clearance around the belly button, where the tissue behaves differently. The outer and front of the thigh is the second choice and is comfortable for people who inject sitting down. The back of the upper arm is the toughest to self-administer because you cannot pinch your own arm with the same hand that holds the pen, so many people recruit a partner for arm doses.

One reassuring point from clinical data: the site itself does not meaningfully change how well GLP-1 drugs like semaglutide and tirzepatide work. Outcomes stay consistent across the abdomen, thigh, and arm. So rotation is not about chasing a more effective spot. It is about protecting the tissue so absorption stays predictable over months and years of weekly shots.

What does it mean to inject subcutaneously, and how deep does the needle go?

Subcutaneous means into the fat layer between skin and muscle, not into the muscle itself. Most modern pens use a short, fine needle designed for this depth. For an average-build adult, a 90-degree angle works. If you are lean and pinch up only a thin fold of fat, a 45-degree angle reduces the chance of hitting muscle, which is more painful and can change absorption.

This matters because peptides like semaglutide were studied and dosed assuming they sit in fat. Push the needle into muscle and you alter the release profile the manufacturer designed around. When in doubt, pinch the skin to lift the fat away from the muscle, then insert.

Why does rotating injection sites actually matter?

Because injecting the same patch of skin over and over causes lipohypertrophy: a buildup of fatty, fibrous tissue that you can often feel as a firm lump or thickened area. Cleveland Clinic describes it as a common consequence of repeated injections into one spot, and the problem is not cosmetic. That damaged tissue does not absorb medication the way healthy fat does.

Here is the number that should make every injector pay attention. Decades of insulin research, summarized in the FITTER Forward expert recommendations published in Mayo Clinic Proceedings, found that when patients move from injecting into lumpy, overused tissue to fresh, lump-free tissue, their insulin requirements often drop by more than 20 percent. That is how much absorption can swing once lipohypertrophy sets in. Peptide therapies are newer, but the tissue biology is the same: scarred, overused fat is unreliable fat.

There is a second, peptide-specific reason. Repeatedly hammering one site can increase local irritation and, with protein-based drugs, theoretically raise the local immune load. Spreading injections across sites keeps any single patch of tissue from carrying the entire burden.

How should you rotate peptide injection sites in practice?

The insulin world has spent forty years figuring this out, and the rules transfer cleanly to weekly peptides. Two principles do most of the work.

Rotate between sites, week to week. The Ozempic prescribing information advises using a different injection site each week when injecting within the same body region. A simple pattern many clinicians teach: abdomen one week, thigh the next, then the other thigh or an arm, then back to a fresh part of the abdomen. The goal is to give any given patch of tissue several weeks to recover before you return.

Rotate within a site, too. The FITTER recommendations are specific here. Spread your injections across an area roughly the size of a postcard, and place each new injection at least one centimeter (about the width of an adult finger) from the last one. Cramming shots into a coin-sized zone, even if you switch from belly to thigh each week, still overloads small patches. One practical scheme is to mentally divide each site into quadrants, use one quadrant per week, and move around in a consistent direction.

A few habits that quietly prevent trouble:

  • Use a fresh needle every time. Reused needles are blunter, hurt more, and concentrate trauma.
  • Keep a simple log or use a rotation app or printed body map so you are not guessing where last week’s shot landed.
  • Run your fingers over old sites before injecting. If you feel a lump, firmness, or numb patch, do not inject there. Give it weeks to months to recover.
  • Avoid injecting into scars, moles, bruises, or broken skin.

How do you know if you already have lipohypertrophy?

Feel for it. Lipohypertrophy shows up as a raised, rubbery, or firm area that may be slightly less sensitive than the surrounding skin. It often forms exactly where injecting is most convenient, which is why favorite spots become problem spots. The counterintuitive trap, noted in patient education from sources like Medical News Today, is that lumpy tissue frequently hurts less to inject into, so people gravitate toward it, which makes it worse.

If you find a lump, stop using that area and switch to healthy tissue. Be aware that moving to fresh tissue can suddenly increase how much active drug you absorb, so watch for stronger effects or side effects after the switch and tell your clinician. For peptides used in weight management, that can mean more pronounced nausea or appetite suppression than you are used to.

A note on unapproved and compounded peptides

Many peptides circulating online, including research-only compounds sold as “not for human use,” are not FDA-approved and carry no manufacturer guidance on injection technique, sterility, or dosing. Compounded semaglutide and tirzepatide exist in a separate, shifting regulatory space and are not the same as the brand-name, FDA-reviewed products. The site and rotation principles in this article are about anatomy and tissue health and apply regardless, but they do not make an unverified compound safe. Source, sterility, and dosing accuracy are separate risks entirely.

If you want the foundations first, our overview of peptides explained covers what these molecules are and how they are used.

Frequently asked questions

Does it matter which site I inject for weight-loss peptides?

For effectiveness, no. Clinical data show semaglutide and tirzepatide work consistently whether injected in the abdomen, thigh, or upper arm. The site matters for comfort, convenience, and protecting your tissue through rotation, not for how well the drug works.

How far apart should each injection be?

At least one centimeter, roughly an adult finger’s width, from any previous injection, and spread across an area about the size of a postcard. This guidance comes from the FITTER injection-technique recommendations and prevents overloading small patches of skin.

Can I inject into the same site every week if I move the spot?

You can return to the same general region, such as the abdomen, as long as each individual injection lands at least a centimeter from the last and you spread shots widely. The damage comes from repeatedly hitting the exact same point, not from using the abdomen repeatedly across a wide area.

What happens if I inject into a lump?

Lipohypertrophy tissue absorbs medication unpredictably, which can blunt or delay the effect. With insulin, switching off lumpy tissue has cut dose requirements by over 20 percent, a sign of how much absorption shifts. Avoid lumps and let them heal.

Is the abdomen safe so close to the belly button?

Stay at least two inches (about five centimeters) away from the navel. The tissue right around it is firmer and absorbs differently, so manufacturers direct injections to the softer fat further out.

This article is for general information only and is not medical advice. Injectable peptides and dosing should be managed with a licensed clinician who knows your health history. Consult your healthcare provider before starting, changing, or self-administering any injectable medication.